Independent. Trusted. Credible.
InGeNAIndustry collaboration for Australia’s genomics future
InGeNA
About
InGeNA is a single voice for Australian industry partners contributing to the rapidly developing field of genomics.
Alliance partners share a vision for Australia’s leadership in the adoption of genomics in healthcare.
– Better health outcomes
– Healthcare value and affordability
– A trusted, equitable and ethical genomics ecosystem
Collaboration across the key sectors of diagnostics/pathology, tech and pharma will ensure long and far-reaching benefits for Australian health consumers.
InGeNA the industry voice for the future of genomics in Australia
HealthData21
Join the first national industry led meeting in genomics bringing together the InGeNA industry alliance in genomics and other key stakeholders. HealthData21 will be held in Melbourne 27 – 28 May, with InGeNA presenting the program on day 1 focussed on “Integrating genomics into care”. Early bird registration is now open.
Webinar
An industry alliance pulling together the Genomics ecosystem in Australia.
This webinar will introduce the InGeNA strategy, engagement and industry collaborations which aims to pull together the genomics ecosystem in Australia and give you a taste of what you’ll see at the HealthData21 conference.
Who we are
InGeNA was formed by a group of industry organisations, hosted by the Australasian Institute of Digital Health (AIDH), to bring a shared perspective on critically important areas underpinning the future of genomics.
- A patient-centred approach
- Digital infrastructure & principles
- Workforce planning & skills
- Government policy making
VISION Realising the full potential of genomics to personalise healthcare
MISSION To harness the collective skills and expertise of industry to integrate genomics into healthcare
Stay connected, stay informed! We welcome your interest. Complete this form to sign up for regular news, events and updates.
Partners
Partners
Collaborative projects
This venture has received funding through the MTPConnect Project Fund Program – a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sector. MTPConnect is supported by the Australian Government Industry Growth Centres Initiative – learn more at mtpconnect.org.au.
Chair Message
“We want Australians to have equity and access to the best that genomics can offer, now and in the future. With industry collaboration through InGeNA, there will be a single voice to have input into strategic planning, governance and funding directions through government, research centres and consumer health.”
David Bunker
InGeNA Chair
InGeNA News
ARCS Precision Medicine Summit: 4 Lunch time session Wednesday 28 April, & 5, 12 and 19 May
We invite you to the ARCS Precision Medicine Summit. Precision medicine is an innovative approach that takes into account individual differences in patients’ genes, environments, and lifestyles. Medicines, technology and digital applications that support a...
Pathology peak signs MOU
InGeNA has formed an alliance with Pathology Technology Australia to collaborate on advocacy and education around precision health. Pathology Technology Australia is the peak body representing Australian sponsors, manufacturers and distributors of in vitro...
InGeNA to be an industry voice for Australian Genomics
InGeNA will provide a united industry voice when it acts as the Industry Advisory Group to the Australian Genomics Health Alliance (Australian Genomics). InGeNA and Australian Genomics have agreed to collaborate and work together on sharing information and...
Genomics technology
The promise of genomics is to help Australians live longer and healthier lives by integrating genomics into the management of health and integrating genomics information and workflows into the health system.
The current focus of genomics is on using individual genetic information to inform tailored healthcare decisions.
Genomics is also expected to have a large impact at the population level in the future. Genomics has the potential to enable earlier diagnosis, improve the identification of the best treatment for the patient, and assist in disease prevention by analysing many genes or the entire genome (comprising all 22,000 genes present in human DNA) at once.
COMING SOON
Resources
A collection of useful references and sources from across Australia’s genomics ecosystem.
Contact
Contact Us
- [email protected]
+61 3 9326 3311
Office
Level 1, 85 Buckhurst Street,
South Melbourne VIC 3205, Australia